Mango Five Family’s Bristol-Myers Squibb BMY Stock Holding History

Mango Five Family’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$103K	–	73
2023 Q4	$103K	Buy	+2,000	New	+$105K	0.04%	61

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mango Five Family's BMY Position: Q1 2024 in Review

Mango Five Family sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 2,000 shares — an estimated $103K sold.

Mango Five Family first reported a position in BMY in Q4 2023 and held it in 1 quarter. The position peaked at $103K in Q4 2023. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Mango Five Family reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Mango Five Family sold 2,000 Bristol-Myers Squibb shares in Q1 2024, an estimated $103K.
Mango Five Family first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 1 quarter.
Mango Five Family's Bristol-Myers Squibb position peaked at $103K in Q4 2023.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Mango Five Family's 13F filing for Q1 2024, filed 16 May 2024.